A few studies have demonstrated that CD103+TRM cells are more abundant in the epithelial compartment of prostate cancer and CD39+TRM cells are closer to cancer cells in melanoma, which provides partial support for our results [34, 35]. The gene discussed is ENTPD1; the disease is prostate carcinoma.